CONTEXT: Transient and permanent postoperative hypoparathyroidism are recognized complications of neck surgery. Postoperative hypoparathyroidism is usually considered permanent when it persists for 6 months; in rare cases, recovery of hypoparathyroidism through 1 year has been described. Recovery of hypoparathyroidism years after diagnosis has not previously been reported. OBJECTIVE: We report four patients being treated with PTH(1-84) in a research protocol who recovered from postoperative hypoparathyroidism many years after onset. METHODS: Recovery from hypoparathyroidism was established by: 1) serum calcium and PTH levels within the normal range off PTH(1-84) treatment for at least 1 week; 2) requirement for daily calcium supplementation reduced to ≤1 g; and 3) no supplemental active vitamin D therapy. RESULTS: Hypoparathyroidism developed in three subjects after repeated neck surgery for primary hyperparathyroidism and in one subject after total thyroidectomy for Graves' disease. Parathyroid tissue autotransplant was performed in two of the four subjects. Two had undetectable PTH levels at study entry, whereas the other two subjects had detectable, although low, PTH levels. Hypoparathyroidism had been present for at least 8 years, and in one case for 16 years. The recovery of parathyroid function followed treatment with PTH(1-84) for 36 to 63 months. CONCLUSIONS: Although it remains relatively rare, this report documents recovery of long-term postoperative hypoparathyroidism many years after the initial diagnosis. A potential role for exogenous PTH is intriguing with several plausible mechanisms.
CONTEXT: Transient and permanent postoperative hypoparathyroidism are recognized complications of neck surgery. Postoperative hypoparathyroidism is usually considered permanent when it persists for 6 months; in rare cases, recovery of hypoparathyroidism through 1 year has been described. Recovery of hypoparathyroidism years after diagnosis has not previously been reported. OBJECTIVE: We report four patients being treated with PTH(1-84) in a research protocol who recovered from postoperative hypoparathyroidism many years after onset. METHODS: Recovery from hypoparathyroidism was established by: 1) serum calcium and PTH levels within the normal range off PTH(1-84) treatment for at least 1 week; 2) requirement for daily calcium supplementation reduced to ≤1 g; and 3) no supplemental active vitamin D therapy. RESULTS:Hypoparathyroidism developed in three subjects after repeated neck surgery for primary hyperparathyroidism and in one subject after total thyroidectomy for Graves' disease. Parathyroid tissue autotransplant was performed in two of the four subjects. Two had undetectable PTH levels at study entry, whereas the other two subjects had detectable, although low, PTH levels. Hypoparathyroidism had been present for at least 8 years, and in one case for 16 years. The recovery of parathyroid function followed treatment with PTH(1-84) for 36 to 63 months. CONCLUSIONS: Although it remains relatively rare, this report documents recovery of long-term postoperative hypoparathyroidism many years after the initial diagnosis. A potential role for exogenous PTH is intriguing with several plausible mechanisms.
Authors: Oliver Thomusch; Andreas Machens; Carsten Sekulla; Jörg Ukkat; Michael Brauckhoff; Henning Dralle Journal: Surgery Date: 2003-02 Impact factor: 3.982
Authors: John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders Journal: J Bone Miner Res Date: 2011-10 Impact factor: 6.741
Authors: Mishaela R Rubin; David W Dempster; James Sliney; Hua Zhou; Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Maryann Dellabadia; Rebecca Ives; Donald J McMahon; Chiyuan Zhang; Shonni J Silverberg; Elizabeth Shane; Serge Cremers; John P Bilezikian Journal: J Bone Miner Res Date: 2011-11 Impact factor: 6.741
Authors: Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chiyuan Zhang; Rebecca Ives; Amanda Tulley; James Sliney; Serge C Cremers; John P Bilezikian Journal: J Clin Endocrinol Metab Date: 2012-11-15 Impact factor: 5.958
Authors: Tanja Sikjaer; Anne Kristine Amstrup; Lars Rolighed; Soren Geill Kjaer; Leif Mosekilde; Lars Rejnmark Journal: J Bone Miner Res Date: 2013-10 Impact factor: 6.741
Authors: Natalie E Cusano; Mishaela R Rubin; Chiyuan Zhang; Laura Anderson; Elizabeth Levy; Aline G Costa; Dinaz Irani; John P Bilezikian Journal: J Clin Endocrinol Metab Date: 2014-08-19 Impact factor: 5.958
Authors: Laura Guglielmetti; Sina Schmidt; Mirjam Busch; Joachim Wagner; Ali Naddaf; Barbara Leitner; Simone Harsch; Andreas Zielke; Constantin Smaxwil Journal: J Clin Med Date: 2022-06-03 Impact factor: 4.964